GLP-1 & Metabolic Health
2 articles. The GLP-1 drug era, read on endpoints: head to head trials, body composition, and what happens when the treatment stops being the story and the comparison starts.
Browse
Sections tell you where a story ran. Topics tell you what it is about. Every article on the site is filed under at least one topic; start from the question, not the headline.
2 articles. The GLP-1 drug era, read on endpoints: head to head trials, body composition, and what happens when the treatment stops being the story and the comparison starts.
1 article. Biological age, epigenetic clocks and rejuvenation claims, held to one standard: several clocks, agreeing, by more than the noise.
2 articles. Lipids, blood pressure and cardiovascular risk: biomarkers on one side, events on the other, and the daylight between them.
2 articles. Muscle mass, strength and body composition: what training and drugs actually change, and how the change was measured.
1 article. New AI models and the benchmarks that grade them: what the index measures, what it misses, and what is actually available to use.
2 articles. AI where it meets work, classrooms and regulators: trials of the tools, and the fight over who oversees the overseers.
1 article. Wearables and the signals they can actually support: rhythms, sleep, and the line between a pattern and a cause.
1 article. Sleep, memory, mood and the aging brain: what the human data shows, and what is still mouse work.
1 article. The house method: how to read a study, a chart or a claim, in plain English, with the checks done in public.
One email a week: the 5 facts that mattered in AI, health and longevity, each checked against the original source. No spam. Unsubscribe in one click.
By subscribing you agree to receive the newsletter. See the privacy policy.